- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 403/06 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Patent holdings for IPC class C07D 403/06
Total number of patents in this class: 3367
10-year publication summary
|
228
|
189
|
225
|
242
|
199
|
159
|
186
|
198
|
180
|
117
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7939 |
69 |
| Boehringer Ingelheim International GmbH | 4645 |
49 |
| Takeda Pharmaceutical Company Limited | 2703 |
49 |
| Novartis AG | 10727 |
45 |
| Merck Sharp & Dohme LLC | 3748 |
45 |
| VALO Health, Inc. | 172 |
39 |
| Janssen Pharmaceutica N.V. | 3376 |
38 |
| Bristol-myers Squibb Company | 4872 |
36 |
| Hoffmann-La Roche Inc. | 3454 |
36 |
| LG Chem, Ltd. | 17636 |
36 |
| Achillion Pharmaceuticals, Inc. | 164 |
33 |
| Mindset Pharma Inc. | 57 |
32 |
| Bayer Pharma AG | 1052 |
27 |
| Cancer Research Technology Limited | 525 |
26 |
| Merck Patent GmbH | 5814 |
25 |
| Astex Therapeutics Limited | 242 |
24 |
| Taisho Pharmaceutical Co., Ltd. | 866 |
22 |
| Dana-Farber Cancer Institute, Inc. | 2574 |
19 |
| Schering Corporation | 443 |
18 |
| The Regents of the University of California | 20015 |
17 |
| Other owners | 2682 |